These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 4147324)

  • 1. [Treatment of acute intermittent porphyria].
    Bielawski W; Kaszewska-Jablońska I
    Pol Arch Med Wewn; 1973 Jun; 50(6):589-93. PubMed ID: 4147324
    [No Abstract]   [Full Text] [Related]  

  • 2. [Catamnestic studies in porphyria cutanea tarda with special reference to therapy].
    Barth J; Petter O
    Z Gesamte Inn Med; 1971 Jan; 26(2):66-74. PubMed ID: 5560767
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapy of porphyrias].
    Burg G
    Dtsch Med Wochenschr; 1971 May; 96(21):914-5. PubMed ID: 4996324
    [No Abstract]   [Full Text] [Related]  

  • 4. Acute intermittent porphyria in Poland.
    Darocha T; Gregor A
    S Afr Med J; 1971 Sep; ():204-17. PubMed ID: 5150281
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of propranolol in acute intermittent porphyria].
    Schwarz D; Mertin J
    Nervenarzt; 1973 Dec; 44(12):648-51. PubMed ID: 4150309
    [No Abstract]   [Full Text] [Related]  

  • 6. Propranolol in acute intermittent porphyria.
    Menawat AS; Panwar RB; Kochar DK; Joshi CK
    Postgrad Med J; 1979 Sep; 55(646):546-7. PubMed ID: 514931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapy of acute viral hepatitis].
    Heilmeyer L; Beck K
    Munch Med Wochenschr; 1969 Apr; 111(15):837-46. PubMed ID: 4327520
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of the porphyrias].
    Horie Y; Okano J; Kitaoka S; Tajima F; Kawasaki H
    Nihon Rinsho; 1995 Jun; 53(6):1456-62. PubMed ID: 7542353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hemodialysis therapy of acute intermittent porphyria].
    Schirmer K; Röder H
    Z Gesamte Inn Med; 1973 Oct; 28(19):Suppl:299-301. PubMed ID: 4766078
    [No Abstract]   [Full Text] [Related]  

  • 10. [Combination therapy of porphyria cutanea tarda using chloroquine and bloodletting therapy].
    Horkay I; Nagy E
    Z Hautkr; 1980 Jun; 55(12):813-6. PubMed ID: 7415362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of bloodletting on the physiologic disorders of acute intermittent porphyria: anesthesia problems].
    Perrot H; Thivolet J
    Lyon Med; 1969 Apr; 221(14):791-2 passim. PubMed ID: 5398686
    [No Abstract]   [Full Text] [Related]  

  • 12. [Experiences with iron elimination therapy in porphyria cutanea tarda].
    Haneke E; Schwartze G
    Z Gesamte Inn Med; 1971 Nov; 26(22):710-6. PubMed ID: 5141034
    [No Abstract]   [Full Text] [Related]  

  • 13. [Erythropoietic protoporphyria (II. Pathogenesis, physiopathology and treatment)].
    Solís Herruzo JA; Pérez Peña F
    Rev Clin Esp; 1973 Apr; 129(1):1-14. PubMed ID: 4574941
    [No Abstract]   [Full Text] [Related]  

  • 14. [Chloroquine therapy in porphyria cutanea tarda].
    Snitker G
    Ugeskr Laeger; 1971 Aug; 133(33):1605-10. PubMed ID: 5099470
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immunizing effect of exchange transfusion in the treatment of acute porphyria].
    Maczyńska-Rusiniak B
    Pol Tyg Lek; 1966 Nov; 21(47):1799-802. PubMed ID: 5979516
    [No Abstract]   [Full Text] [Related]  

  • 16. [A summary of twelve-year experience on the therapy of porphyria cutanea tarda (author's transl)].
    Resl V
    Cesk Dermatol; 1978; 53(5):336-43. PubMed ID: 729018
    [No Abstract]   [Full Text] [Related]  

  • 17. Porphyria cutanea tarda treated by repeated venesection: clinical and biochemical response.
    Baker H; Turnbull A
    Proc R Soc Med; 1969 Jun; 62(6):590-2. PubMed ID: 5802737
    [No Abstract]   [Full Text] [Related]  

  • 18. [Current therapeutic methods in porphyria cutanea tarda].
    Giannotti B
    G Ital Dermatol Venereol; 1984; 119(3):167-9. PubMed ID: 6746011
    [No Abstract]   [Full Text] [Related]  

  • 19. [Acute familial prophyria. Treatment with exchange transfusion].
    BALLIVET J; MICHIELS R
    J Med Lyon; 1960 May; 41():667-76. PubMed ID: 13796280
    [No Abstract]   [Full Text] [Related]  

  • 20. Changes of myocardial functions in acute hepatic porphyrias. Role of heme arginate administration.
    Kordac V; Kozáková M; Martásek P
    Ann Med; 1989 Aug; 21(4):273-6. PubMed ID: 2551350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.